CORRECTION: Previous posts on new product/substitute
My apologies. The new product or substitute for Anatabloc was briefly mentioned in Thursday's Patrick Cox newsletter, which I see now I am not permitted to post or quote. The possible substitute is probably not from RCPI anyway.
Apparently he will have more to say on anatabine citrate and about the substitute in the coming weeks, but I will probably not have access to it unless I decide to subscribe to Cox's newsletter. The newsletters are released on Thursdays.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.